FDA Releases Guidance on Quality Considerations for Inhaled Drugs

Drug GMP Report
A A
The FDA published draft guidance on metered dose and dry powder inhalers highlighting considerations for critical quality attributes.

To View This Article:

Login

Subscribe To Drug GMP Report